Aytu Biopharma (NasdaqCM:AYTU) 2026 Investor Day Transcript
2026-01-20 17:02
Aytu Biopharma Investor Day Summary Company Overview - **Company**: Aytu Biopharma (NasdaqCM:AYTU) - **Event**: 2026 Investor Day held on January 20, 2026 - **Product Launch**: Official launch of Exxua, the first and only 5-HT1A agonist for major depressive disorder (MDD) [1][2] Key Points on Exxua - **Mechanism of Action**: Exxua (Gepirone) is a selective 5-HT1A agonist approved for MDD in adults, functioning as a once-daily extended-release tablet [3][5] - **Unique Features**: Unlike SSRIs and SNRIs, Exxua does not inhibit re-uptake but activates the 5-HT1A receptor both presynaptically and postsynaptically, enhancing neurotransmission of serotonin and dopamine [3][28] - **Safety Profile**: Exxua has a favorable safety profile, with no significant increase in sexual dysfunction or weight gain compared to placebo [42][63] Clinical Data and Efficacy - **Clinical Trials**: Two eight-week randomized, double-blind, placebo-controlled trials demonstrated statistically significant improvement in depression scores [48][51] - **Primary Efficacy Measures**: Utilized the Hamilton Depression Rating Scale (HAM-D) and Montgomery-Åsberg Depression Rating Scale [48] - **Results**: - Statistically significant improvement observed as early as week two, with about 50% of patients showing improvement [52][54] - Approximately one-third of patients achieved remission by week eight [56] Unmet Treatment Needs - **Prevalence of MDD**: In 2021, approximately 21 million Americans (8.3%) experienced major depression, with higher rates in women and younger populations [33][34] - **Treatment Challenges**: Many patients switch medications due to intolerable side effects, with 50% failing to achieve remission after multiple treatments [36][38] - **Importance of Early Intervention**: Early use of Exxua is recommended to avoid treatment-resistant depression and improve patient outcomes [68][69] Side Effects and Tolerability - **Common Side Effects**: Mild to moderate side effects include dizziness, nausea, and insomnia, but these did not lead to significant discontinuation rates [59][63] - **Weight and Sexual Function**: Exxua does not cause significant weight gain or sexual dysfunction, addressing major concerns associated with traditional antidepressants [42][63] Expert Insights - **Ideal Patient Profile**: Exxua is suitable for patients who prioritize avoiding sexual dysfunction and weight gain, and should be considered early in treatment [67][68] - **Combination Therapy Potential**: There is potential for Exxua to be used in combination with other therapies, but it can also serve effectively as a monotherapy [70] Conclusion - Aytu Biopharma's Exxua represents a significant advancement in the treatment of major depressive disorder, with a unique mechanism of action, favorable safety profile, and potential to address unmet needs in the patient population [1][28][42]
PetroTal (OTCPK:PTAL.F) Update / briefing Transcript
2026-01-20 16:02
PetroTal (OTCPK:PTAL.F) Update / briefing January 20, 2026 10:00 AM ET Company ParticipantsCamilo McAllister - CFOManolo Zúñiga - President and CEOOperatorGood afternoon. Thank you for joining PetroTal's 2026 Guidance Webcast. Your presenters today are Manolo Zúñiga, President and CEO, and Camilo McAllister, CFO. Questions can be submitted via the platform, and we'll do our best to answer as many as possible in the available time. Now I hand over to Manolo and Camilo. Thank you.Manolo ZúñigaThank you, Mark, ...
Corvus Pharmaceuticals (NasdaqGM:CRVS) Update / briefing Transcript
2026-01-20 14:02
Corvus Pharmaceuticals Conference Call Summary Company Overview - **Company**: Corvus Pharmaceuticals (NasdaqGM:CRVS) - **Date**: January 20, 2026 - **Key Executives Present**: Dr. Richard Miller (CEO), Leif Lea (CFO), Jeff Arcara (CBO), Dr. Ben Jones (SVP, Pharmaceutical Development), Dr. Suresh Mahabhashyam (VP, Clinical Development) [2][3] Core Industry and Product Focus - **Industry**: Pharmaceuticals, specifically focusing on immune diseases and atopic dermatitis - **Product**: Socalitinib, a first-in-class oral drug targeting interleukin-2 inducible T-cell kinase (ITK) [4][39] Key Findings and Data from Clinical Trials - **Phase I Clinical Trial Results**: - Socalitinib shows potential as a leading therapy for atopic dermatitis, achieving significant clinical results [5][6] - Efficacy metrics: - EASI 75: 75% of patients - EASI 90: 25% of patients - IGA 0/1: 33% of patients - Mean percent reduction in EASI score: 72% at eight weeks [6][24] - Responses are durable, with continued reduction in EASI scores post-treatment [6][21] - **Cohort 4 Specifics**: - 24 patients enrolled with a one-to-one randomization of active versus placebo - Treatment duration extended to eight weeks, confirming positive results from earlier cohorts [18][24] - EASI score reduction: 72% for Socalitinib vs. 40% for placebo, p-value of 0.035 [24][26] - **Prior Systemic Therapy**: - 35% of all patients had prior therapies, with 50% in cohort 4 - Socalitinib demonstrated efficacy in patients with prior systemic therapy, indicating no resistance [27][30] Mechanism of Action - Socalitinib selectively inhibits ITK, leading to a rebalancing of the immune system without causing immunosuppression [9][10] - Induction of T regulatory cells (Tregs) contributes to durable suppression of inflammation [21][30] Market Opportunity - Over 3 million patients with moderate to severe atopic dermatitis, with a significant unmet need for safe and effective oral therapies [15][38] - The market for atopic dermatitis is projected to grow to $170 billion by 2030, with oral agents expected to gain a larger share [38] Future Plans - Initiation of a phase 2 randomized placebo-controlled trial in atopic dermatitis, planned to enroll 200 patients [37][39] - Exploration of Socalitinib's efficacy in other immune diseases, including hidradenitis suppurativa and asthma [39] Safety Profile - No new safety signals observed in cohort 4; adverse events (AEs) were similar between active and placebo groups [31][55] - Historical data from lymphoma studies indicate a strong safety profile, with no patients discontinuing due to safety concerns [54][55] Conclusion - Socalitinib is positioned as a promising treatment for atopic dermatitis and potentially other immune diseases, with a strong clinical efficacy and safety profile [39][40]
Western Midstream Partners (NYSE:WES) Fireside chat Transcript
2026-01-20 13:07
Summary of Western Midstream Partners Fireside Chat Company Overview - **Company**: Western Midstream Partners (NYSE: WES) - **Industry**: Midstream Energy Sector, specifically focused on natural gas gathering and processing in the Delaware Basin Key Points Contract Amendments - **Renegotiated Contracts**: Western Midstream announced the renegotiation of natural gas gathering and processing contracts with Occidental Petroleum and a new agreement with ConocoPhillips [2][3] - **Contract Structure Changes**: Transition from a legacy cost-of-service structure to a simplified fixed-fee structure, enhancing competitiveness for acreage serviced by WESS [3] - **Volumetric Protections**: The amended contract with Occidental includes substantial minimum volume commitments, mitigating future throughput risk [3] Financial Implications - **Common Units Transfer**: Occidental will transfer approximately 15.3 million WESS common units, valued at about $610 million, which will decrease OXY's ownership in WESS from 42% to 40% [6] - **Annual Distribution Savings**: The transaction is expected to yield annual distribution savings of over $56 million starting in 2026 [6] - **Adjusted EBITDA Impact**: The total contract liability will increase to approximately $1.2 billion, with about $165 million recognized as revenue annually from 2026 to 2032 [7][8] Revenue Recognition - **Contract Liability**: The contract liability associated with the OXY agreement was $560 million as of December, with revenue recognition beginning in 2026 [10] - **Operating Cash Flow**: Starting in 2026, operating cash flows will reflect only the new fixed-fee rates, while revenues will include recognition of the contract liability [11] Cost Management - **Cost Reduction Initiatives**: WESS has implemented a cost reduction initiative, resulting in an 8% decrease in operations and maintenance costs in Q3 2025 compared to Q3 2024 [15] - **Offsetting Cash Flow Reductions**: Ongoing distribution savings and cost reductions are expected to fully offset the reduction in free cash flow due to the transition to a fixed fee structure [16] Risk Mitigation - **Recontracting Risk**: The new amendments with OXY significantly reduce the percentage of WESS revenue generated by cost-of-service rates, with only 9% of total revenue remaining subject to such rates post-amendment [17][18] - **Long-term Contracts**: Significant fixed fee contracts with OXY are effective through the mid to late 2030s, providing stability [18][19] Strategic Outlook - **Future Growth**: WESS is positioned to capitalize on future growth in the Delaware Basin, with a focus on improving cost structure and process efficiency while pursuing growth opportunities [20] Additional Insights - **Market Positioning**: The amendments and strategic initiatives are aimed at enhancing WESS's competitiveness in the midstream market, reflecting a proactive approach to evolving market conditions [20]
Victory Giant ( CH) (Buy) - Major beneficiary of global AI leader’s tech upgrade...
2026-01-20 01:50
Summary of Victory Giant (300476.SZ) Conference Call Company Overview - **Company Name**: Victory Giant (VGT) - **Ticker**: 300476.SZ - **Industry**: Technology, specifically PCB (Printed Circuit Board) manufacturing - **Headquarters**: Huizhou, Guangdong, China - **Main Applications**: AI servers, network equipment, automotive, consumer electronics, healthcare appliances [11][28] Key Points and Arguments Financial Performance and Forecasts - **Revenue and Earnings Adjustments**: - FY25F revenue forecast slightly lowered by 1% to CNY19,698 million, and earnings forecast reduced by 2% to CNY4,740 million due to slower capacity ramp-up in Q4 FY25F [1][14] - FY26-27F revenue forecasts increased by 5-17% and earnings forecasts raised by 9-22% reflecting higher value content from existing customers and new customer acquisitions [1][14] - **Target Price**: - Target price cut to CNY333, implying an 18% upside, based on a P/E ratio of 35x FY26F EPS of CNY9.51, aligning with historical median P/E [1][19] - **Market Capitalization**: Approximately USD 35.2 billion [6][28] Market Dynamics - **AI and PCB Demand**: - VGT is expected to benefit significantly from the HDI PCB upgrade driven by global AI customers, with a key AI customer projected to contribute over 40% of total revenue in FY26-27F [2][19] - Revenue CAGRs estimated at 84% for HDI and 36% for HLC segments over FY25-27F [2] Supply Chain Management - **Component Shortages**: - Ongoing shortages in components and equipment due to high demand for AI PCBs, including high-end copper foil and laser drilling equipment [3] - VGT's effective supply chain management and strong relationships with global suppliers position the company favorably to mitigate these shortages [3] Financial Metrics - **Earnings Growth**: - Normalized EPS growth projected at 310.6% for FY25 and 73.2% for FY26 [4][15] - **Profit Margins**: - Gross profit margin expected to improve to 35.3% in FY26 and 38.6% in FY27 [4][15] - **Debt Management**: - Net debt/equity ratio projected to decrease to 26.5% in FY25F and net cash position by FY27F [4][10] Risks and Challenges - **Downside Risks**: - Key customers diversifying supply chains and increased competition from peers [20][30] - Potential technological changes (e.g., COWOP) that could alter the competitive landscape [20][30] - Slower technology upgrades in the AI PCB market and geopolitical tensions [20][30] ESG Considerations - VGT's role in providing electronic products for data centers and AI infrastructure highlights its social responsibility, though environmental impacts from manufacturing processes are noted [13] Conclusion Victory Giant is positioned as a leading player in the PCB manufacturing sector, particularly benefiting from the AI technology upgrade trend. Despite some adjustments in revenue and earnings forecasts, the company maintains a positive growth outlook driven by strong demand and effective supply chain management. However, it faces risks from market competition and technological changes that could impact its future performance.
Sunny Optical (2382.HK)_ Mgmt. visit_ AI _ AR glasses ramp up; Smartphone camera specification upgrade to support growth
2026-01-19 02:32
Summary of Sunny Optical Conference Call Company Overview - **Company**: Sunny Optical (2382.HK) - **Industry**: Technology, specifically focusing on AI/AR glasses and smartphone camera modules Key Points and Arguments 1. **Positive Outlook on AI/AR Glasses**: Management expressed optimism regarding the growth of AI/AR glasses, highlighting their ability to provide point-of-view shots, hands-free communication, and AI access. The expected shipment for AI/AR glasses in China is projected to reach 3.7 million units in 2026 and 7.0 million units in 2027, with a compound annual growth rate (CAGR) of 32% anticipated from 2027 to 2030, reaching 16 million units by 2030 [1][2][3] 2. **Smartphone Camera Specification Upgrade**: The average number of cameras per smartphone peaked at 3.8 in 2022 but has decreased to 3.1 in 2025 year-to-date (YTD). However, the penetration of smartphones with cameras of 20MP or more has increased to 57% in 2025 YTD, up from 52% in 2024 [1][3] 3. **Market Dynamics**: Despite potential single-digit declines in the smartphone end market in 2026 due to rising memory costs, management remains positive about the company's prospects. Key catalysts include: - Upgrades in smartphone camera specifications, including miniature cameras and variable aperture cameras - Enhanced product mix in smartphone cameras, focusing on higher-tier brands - Increased demand for cameras in vehicles, with L3 autonomous vehicles potentially using 11-15 cameras [3][4] 4. **Financial Projections**: The company has a 12-month target price of HK$91.1, based on a price-to-earnings (P/E) ratio of 21.6x for 2026E. This target is consistent with Sunny Optical's 5-year trading range. The current price is HK$66.25, indicating a potential upside of 37.5% [4][9] 5. **Risks**: Several risks were identified, including: - Variability in competition within the handset lens market - Uncertainty in shipment growth for camera modules - Fluctuations in operational expenditure ratios - Currency exchange rate impacts, particularly regarding the Chinese Yuan [8] Additional Important Information - **Earnings Growth**: Sunny Optical has experienced strong earnings growth and gross margin (GM) expansion historically, particularly as its product mix shifted from camera modules to handset lenses. Future positivity may depend on the resumption of GM growth [2] - **Valuation Metrics**: The company is currently rated as Neutral, reflecting a fair valuation in a competitive smartphone camera market. Analysts may revise this rating positively if GM trends upward [2][4] - **Market Capitalization**: As of the report, Sunny Optical's market cap is HK$72.5 billion (approximately $9.3 billion) [9] This summary encapsulates the key insights from the conference call regarding Sunny Optical's strategic direction, market conditions, and financial outlook, providing a comprehensive overview for potential investors.
From Tokens to Burgers – A Water Footprint Face-Off
2026-01-19 02:28
Summary of the Conference Call on Datacenter Water Usage Industry Overview - The discussion centers around the water consumption of datacenters, specifically comparing the water footprint of Elon Musk's Colossus 2 datacenter with that of an average In-N-Out burger restaurant [5][7][32]. Key Points and Arguments 1. **Datacenter Water Usage Scrutiny**: Datacenter water usage is increasingly criticized, with some projects being paused or canceled due to concerns over water consumption. However, the debate is considered overstated as key variables like cooling architecture, power source, and local water scarcity are often overlooked [5][6]. 2. **Lack of Standardization**: There is no standard for water accounting in datacenters, complicating comparisons. Different metrics can lead to misleading conclusions about water consumption [6][5]. 3. **Colossus 2 Water Footprint**: - Colossus 2 is projected to consume approximately 1 million gallons of water per day, but detailed calculations reveal an annual water footprint of 346 million gallons (1,310 million liters) or about 0.9 million gallons per day [21][32]. - The water footprint includes direct usage for cooling and indirect usage from chip manufacturing, with a significant portion coming from cooling processes [21][10]. - The cooling system employs both dry and adiabatic cooling methods, which impacts water consumption rates [15][11]. 4. **In-N-Out Water Footprint**: - An average In-N-Out store has an estimated annual water footprint of 147 million gallons, primarily from the beef used in their burgers [30][32]. - The water footprint of a Double-Double burger is calculated to be 245 gallons (927 liters), with beef accounting for 95% of this footprint [29][26]. 5. **Comparative Analysis**: The water footprint of Colossus 2 is approximately 2.5 times that of an average In-N-Out store, suggesting that the water consumption debate may be misdirected [32][33]. 6. **Economic Value of Datacenters**: The economic value of the output from datacenters, measured in tokens, is highlighted as a critical factor in the water consumption debate. The analysis suggests that a single burger's water footprint could equate to using the datacenter's services for 668 years [35][34]. Additional Important Insights - **Water Recycling Initiatives**: Colossus 2 is planning to build a water recycling plant to utilize municipal wastewater, potentially making it a net-zero water datacenter [37]. - **Contextualizing Water Usage**: The discussion emphasizes the need to contextualize water usage debates, comparing it to everyday consumption in the food industry, particularly in beef production [38][5]. This summary encapsulates the critical aspects of the conference call, focusing on the water consumption of datacenters versus the food industry, particularly burgers, while highlighting the need for a nuanced understanding of water usage metrics.
Arteris (NasdaqGM:AIP) FY Conference Transcript
2026-01-16 21:02
Arteris (NasdaqGM:AIP) FY Conference Summary Company Overview - **Industry**: Semiconductor IP - **Company**: Arteris IP - **Focus**: Data movement within semiconductor chips, utilizing network-on-chip (NoC) technology to enhance data processing, storage, and transfer capabilities [3][4] Core Business and Technology - **Products**: - Ncore: Cache-coherent product for processor subsystems - Non-coherent NoC IP: For data transport across chips - FlexGen: Automates NOC IP generation, improving design speed by 10x and reducing design length by up to 30% [9] - **Acquisitions**: - Magillem (2020): Enhances SoC connectivity and hardware-software integration - Cycuity (2023): Focuses on hardware security verification [14][15] Market Dynamics - **Increasing Complexity**: Driven by AI applications, chiplets, and the need for robust data movement solutions [5][6] - **AI Focus**: Approximately 50% of design starts are for AI applications, including automotive and data center solutions [10][11] - **Customer Base**: Over 230 active customers, including major global companies and startups [7][8] Financial Performance - **Third Quarter Highlights**: - Revenue growth of 18%, with a significant increase in remaining performance obligations (RPO) by 34% year-over-year, reaching approximately $105 million [19][20] - Positive free cash flow despite negative profitability due to deferred revenue model [17][18] - **Future Guidance**: - Projected revenue around $69 million for the upcoming year, with a target for license revenue growth in the high teens to low 20s percent [34] Growth Strategy - **R&D Investment**: Commitment to maintaining a robust R&D program, with plans to release one new product annually [13][30] - **Market Focus**: Targeting high-growth areas such as automotive, AI, and chiplet solutions [13][14] - **Inorganic Growth**: Potential for further acquisitions to enhance capabilities and market reach [22][23] Customer Relationships - **Retention Rate**: Over 90% customer retention, exemplified by a long-term relationship with Mobileye [12] - **Royalty Streams**: Diversification of royalty sources, with a significant portion now coming from automotive applications [26][27][28] Conclusion - Arteris is positioned for growth in the semiconductor IP market, leveraging its innovative technologies and strong customer relationships to navigate the complexities of modern chip design and data movement. The company is focused on maintaining financial health while investing in R&D and exploring strategic acquisitions to enhance its market position [14][34]
Lightwave Logic (NasdaqCM:LWLG) FY Conference Transcript
2026-01-16 21:02
Summary of Lightwave Logic FY Conference Call Company Overview - **Company**: Lightwave Logic (NasdaqCM: LWLG) - **Industry**: Optical Networking and AI Networking Hardware - **Key Technology**: Development of electro-optic polymer materials, specifically Perkinamine, which allows modulation of light at speeds exceeding 100 billion times per second [2][3][4] Core Points and Arguments - **Technology Significance**: The ability to modulate light quickly is crucial for optical networks, enhancing data transmission rates over fiber optics [3][4] - **Material Development**: Lightwave Logic has transitioned from research to commercialization, focusing on the productization of their electro-optic polymer materials [6][20] - **Management Changes**: A new management team has been established to drive the company towards product development, including hiring a new CTO and VP of Engineering with extensive industry experience [6][7][9] - **Market Opportunity**: The addressable market for transceivers and co-packaged optics (CPO) is projected to approach $30 billion by 2028, with the modulator segment estimated between $1 billion and $2.5 billion [20][24] - **Revenue Model**: The business model combines material sales with reference designs and process design kits, aiming for gross margins exceeding 60% [24][33] Industry Dynamics - **AI Networking Demand**: The increasing demand for high bandwidth and low power consumption in data centers is driving innovation and engagement with potential customers [10][40] - **Competitive Landscape**: Lightwave Logic's polymer technology is positioned against traditional materials like silicon photonics and lithium niobate, with advantages in speed, power consumption, and integration capabilities [18][31] - **Reliability Breakthrough**: A significant milestone was achieved in 2025 when the company passed reliability tests for their materials, enhancing market confidence [19][40] Future Directions - **Expansion into Quantum Computing**: Lightwave Logic is exploring opportunities in quantum applications, establishing partnerships to build a quantum ecosystem [21][23] - **Production Infrastructure**: Investments are being made to scale production capabilities in preparation for anticipated revenue growth in 2027 and 2028 [44][46] - **Customer Engagement**: The company has secured engagements with major Fortune Global 500 companies, validating its technology and market position [27][39] Financial Position - **Cash Reserves**: The company entered 2026 with over $70 million in cash, providing a strong runway for continued investment and growth [33] - **Burn Rate**: The current burn rate is approximately $20 million, with expected increases in investment for production and technical support [44] Additional Insights - **Intellectual Property**: Lightwave Logic holds over 80 patents, covering various aspects of their technology, which is crucial for competitive advantage [16][32] - **Geopolitical Stability**: The company is not significantly affected by geopolitical issues, as its raw materials are widely available and it does not rely on rare earth materials [32] This summary encapsulates the key points discussed during the Lightwave Logic FY Conference Call, highlighting the company's technology, market opportunities, competitive positioning, and future strategies.
GigaCloud Technology (NasdaqGM:GCT) FY Conference Transcript
2026-01-16 20:17
GigaCloud Technology FY Conference Summary Company Overview - **Company Name**: GigaCloud Technology (NasdaqGM:GCT) - **Industry**: B2B E-commerce Marketplace focused on big and bulky items, primarily furniture - **Founded**: 16 years ago, initially in Japan and the U.K., entered the U.S. market in 2013 - **Public Listing**: Went public in 2022 - **Headquarters**: El Monte, Greater Los Angeles Area Key Financial Highlights - **Revenue**: Generated $333 million in the last quarter, reflecting a 10% year-over-year growth [4] - **Net Profit**: Achieved a net profit of $33 million, with an EPS of $0.99, which is a 1% increase from the previous year [5] - **Cash Generation**: Generated over $70 million from operations in the last quarter, indicating strong cash flow management [6] - **Share Repurchase**: Bought back approximately 10% of the company in the last 12 months [6] - **IPO Proceeds**: Raised roughly $41 million in the IPO, with $200 million spent on share repurchases and acquisitions over three years [6] Market Performance - **Growth in Europe**: European revenue grew 70% year-over-year, now representing one-third of total revenue, compensating for slower U.S. growth [7][8] - **Addressable Market**: The wholesale furniture market in the U.S. is estimated at $40-$50 billion, with GigaCloud capturing a small portion [25] Business Model - **SFR Model**: GigaCloud operates under a Supplier Fulfilled Retailing (SFR) model, which allows suppliers to fulfill orders directly to consumers, reducing logistics costs and improving supply chain efficiency [10][18] - **Inventory Management**: The model reduces inventory risk for retailers by allowing suppliers to manage inventory, thus minimizing forecasting errors [12][13] - **Revenue Streams**: Revenue is generated from both 1P (direct sales) and 3P (third-party sales) logistics, with take rates ranging from 35% to over 50% depending on shipping costs [19][34] Competitive Advantages - **Technology Utilization**: GigaCloud leverages technology to streamline transactions and reduce operational costs compared to traditional methods [26][27] - **Fragmented Market**: The furniture industry is highly fragmented, with no single manufacturer dominating, allowing GigaCloud to consolidate volume and reduce costs [27][37] - **Warehouse Infrastructure**: Operates 25 warehouses across the U.S. to facilitate efficient order fulfillment and inventory management [15][35] Challenges and Risks - **Market Conditions**: The company faces challenges from consumer demand fluctuations and tariff impacts, particularly in the U.S. market [5][30] - **Inventory Risk**: Managing inventory for non-standard items poses a significant risk, but GigaCloud's experience mitigates this [32] Future Outlook - **Growth Strategy**: Focus on expanding the number of participants in the ecosystem and increasing reliance on GigaCloud's services [24] - **Market Transition**: Aiming to transition more traditional businesses to the GigaCloud model, showcasing the benefits of technology in the supply chain [25] Recognition - **Awards**: GigaCloud was recognized by Forbes as the number one U.S.-based company with a market cap under $2 billion for 2025 and remains in the top 20 for 2026 [4]